IL-1β is produced by myeloid cells and acts as a critical
mediator of host defense during infection and injury. We found that the
intracellular protozoan parasite Toxoplasma gondii induced an
early IL-1β response (within 4 hr) in primary human peripheral blood
monocytes isolated from healthy donors. This process involved up-regulation of
IL-1β, IL-1RN (IL-1 receptor
antagonist), and NLRP3 transcripts, de novo
protein synthesis, and the release of both pro- and mature-IL-1β from
infected primary monocytes. The released pro-IL-1β was cleavable to
mature, bioactive IL-1β in the extracellular space by the protease
caspase-1. Treatment of primary monocytes with the NLRP3 inhibitor MCC950 or
with extracellular potassium significantly reduced IL-1β cleavage and
release in response to T. gondii infection, without affecting
the release of TNF-α, and indicated a role for the inflammasome sensor
NLRP3 and for potassium efflux in T. gondii-induced
IL-1β production. Interestingly, T. gondii infection
did not induce an IL-1β response in primary human macrophages derived
from the same blood donors as the monocytes. Consistent with this finding,
NLRP3 was down-regulated during the differentiation of
monocytes to macrophages and was not induced in macrophages during T.
gondii infection. To our knowledge, these findings are the first to
identify NLRP3 as an inflammasome sensor for T. gondii in
primary human peripheral blood cells and to define an upstream regulator of its
activation through the release of intracellular potassium.